CAR T-cell Therapy for Multiple Myeloma 2021

Immunotherapies in Relapsed/Refractory Multiple Myeloma: 2021 Round-Up and a Look Into the FutureПодробнее

CAR T Cell Therapy in China for Multiple Myeloma - Bjorn Simensen Story at Bioocus BiotechПодробнее

Clinical Activity of BMS-986393, a CAR T cell therapy directed at GPRC5D, in Pts with RRMMПодробнее

CAR T-cell Therapy: Multiple MyelomaПодробнее

Lymphoma: Overview of Chimeric Antigen Receptor (CAR) T cellsПодробнее

HealthTree Podcast: Robert Z. Orlowski, MD, PhD, MD Anderson Myeloma in 2021Подробнее

CAR T-Cell Therapy for Multiple Myeloma at Hadassah Hospital in JerusalemПодробнее

CAR T-Cell Therapy: Fighting Cancer 🤛🏻 #immunologist #cancertreatment #biology #cancer #CARTcellsПодробнее

How to optimize access to CAR-T cell therapies in multiple myelomaПодробнее

Top Doctor & Patient Talk Game Changing Cancer Treatments: How Close is a Cure? (Multiple Myeloma)Подробнее

Patient & Family Webinar: From Best of ASH 2021 to 2022 COVID-19 GuidanceПодробнее

CAR T-Cell Therapy for Multiple MyelomaПодробнее

What is CAR T-cell therapy?Подробнее

CARTITUDE-2: evaluating CAR T therapy Cilta-Cel in multiple myeloma patients who had early relapseПодробнее

Are there trials evaluating CAR T-cell therapy in early disease myeloma patients?Подробнее

nbmtLINK Lunch and Learn Series: Updates and Inspiration Regarding Multiple Myeloma (March 2021)Подробнее

What to Expect with CAR T Cell Therapy and Bispecifics in Myeloma (2022) | Dr. Joshua RichterПодробнее

Our Ongoing Commitment to Multiple Myeloma PatientsПодробнее

Updated Study Results of BCMA/CD19 Dual-Targeting CAR-T GC012F for RRMM PatientsПодробнее

nbmtLINK Lunch and Learn Series: Everything You Need To Know About CAR T-Cell Therapy (June 2021)Подробнее